Protocol Ledger

NCT05923866 · Phase II · ACTIVE NOT RECRUITING

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Interventional Phase II clinical trial protocol NCT05923866 sponsored by Ono Pharmaceutical Co in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-09-22 Enrollment: 92 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05923866
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)92 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05923866
Protocol FieldVerified Registry Value
NCT IdentifierNCT05923866
Consolidated Lead SponsorOno Pharmaceutical Co
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment92 participants (ACTUAL)
Registered Start Date2023-09-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI